Dr. Mark Dybul

Professor of Medicine, Chief Strategy Officer, Center for Global Health Practice and Impact, Georgetown University Medical Center

The Honorable Mark Dybul, MD, is the Chief Strategy Officer of the Center for Global Health Practice and Impact and Professor in the Department of Medicine at Georgetown University Medical Center.  He is also Interim Chair of Purpose Africa, Executive Chair of Purpose Life Sciences and CEO of Renovaro Inc.

Dr. Dybul has worked on HIV and public health for more than 25 years as a clinician, scientist, teacher, and administrator. He served as the Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria (2013-2017) and the US Global Coordinator and Ambassador leading the President’s Emergency Plan for AIDS Relief (PEPFAR).

After graduating from Georgetown Medical School in Washington D.C., Dr. Dybul joined the National Institute of Allergy and Infectious Diseases, as a research fellow under director Dr. Anthony Fauci, where he conducted basic and clinical studies on HIV virology, immunology and treatment optimization, including the first randomized, controlled trial with combination antiretroviral therapy in Africa.  His first supervisor in Dr. Fauci’s laboratory was the Noble Laureate Dr. Drew Weissman.

Mark was one of the founding architects in the formation of PEPFAR. After serving as Chief Medical officer, Assistant, Deputy and Acting Director, he was appointed as its leader in 2006, becoming U.S. Global AIDS Coordinator, with the rank of Ambassador at the level of an Assistant Secretary of State. He served until early 2009.

Mark has written extensively in scientific and policy literature, he is a member of the National Academy of Medicine and has received several Honorary Degrees and awards, including a Doctor of Science, Honoris Causa, from Georgetown University.

    Back
to Top